1. Osteoclast-like giant cells in hepatocellular carcinoma case description and review of the literature
- Author
-
Maxime Dewulf, Anke H. C. Gielen, Marcel den Dulk, Jan Beckervordersandforth, Iryna Samarska, Kees H. C. Dejong, and Stefan A W Bouwense
- Subjects
medicine.medical_specialty ,Cirrhotic liver ,LIVER ,PROGNOSIS ,Hepatocellular carcinoma ,medicine.medical_treatment ,03 medical and health sciences ,0302 clinical medicine ,TUMOR ,medicine ,Overall survival ,Neoadjuvant therapy ,PANCREAS ,MUTATIONS ,business.industry ,General surgery ,General Medicine ,Case description ,medicine.disease ,osteoclast-like giant cells ,Male patient ,Giant cell ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Surgery ,business ,Systematic search - Abstract
Background The presence of osteoclast-like giant cells (OGC) in hepatocellular carcinoma (HCC) is rare and literature on this topic is scarce. In this article, we report on a case of a 77-year-old male patient with HCC with OGC and provide an overview of the current literature. Methods We conducted a systematic search to find all available literature on OGC in HCC. The electronic databases PubMed, Web of Science, Embase and CENTRAL were searched from inception until October 2020. Results Thirteen articles on this topic were identified and were included in this review. Data on 14 patients were available, described in twelve case reports, one patient in a patient series and the present case. Median age of included patients was 68 years. Two patients underwent neoadjuvant therapy prior to surgery. Of the 14 cases, eight tumours with OGC arose in a cirrhotic liver. Oncological outcome in this series was unfavourable, even after surgical resection, with a median disease-free survival of 75 d. Conclusions The presence of OGC in HCC is rare. Current literature is scarce, and suggests an unfavourable outcome in regard to overall survival of HCC.
- Published
- 2021
- Full Text
- View/download PDF